The Venture Codex Logo

The Venture Codex

Barer & Son Capital

2 Barer Lane, Mendham, NJ, 07945, United States

Overview

Venture capital firm investing in healthcare and life sciences.

Founded

2017

Deals · 12mo

0

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

—

Investment portfolio

3rounds
NAMEDATESIZE
AsclepiX Therapeutics
Jun 2020Participated
$35 MSeries A
Viela Bio
Jun 2019Participated
$75 MSeries B
AsclepiX Therapeutics
Nov 2018Led
$5 MOther Equity
AsclepiX Therapeutics
Jun 2020Participated
$35 MSeries A
Viela Bio
Jun 2019Participated
$75 MSeries B
AsclepiX Therapeutics
Nov 2018Led
$5 MOther Equity
3
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Barer & Son Capital: 3 funding rounds are recorded in the selected participation categories.All available history.
Barer & Son Capital: 3 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B01
Other Equity10

Monthly Deal Activity

Barer & Son Capital: 3 deals are recorded across 96 months.All available history.
Barer & Son Capital: 3 deals are recorded across 96 months. All available history
MonthDeals
Nov '181
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '191
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '201
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Barer & Son Capital: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Barer & Son Capital: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3

Deal Size Distribution

Barer & Son Capital: 3 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Barer & Son Capital: 3 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M0
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Barer & Son Capital: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Barer & Son Capital: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Barer & Son Capital: 11 co-investors are shown, with Rapha Capital Management sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Barer & Son Capital: 11 co-investors are shown, with Rapha Capital Management sharing 2 recorded deals. All available history
Co-investorShared deals
Rapha Capital Management2
Cormorant Asset Management1
Goldman Sachs1
HBM Healthcare Investments1
Perceptive Advisors1
Piedmont Capital Partners1
Salem Partners1
TEDCO1
Temasek1
Terra Magnum Capital Partners1
Viking Global Investors1

Investment Strategy

Barer & Son Capital: Led accounts for 33% and participating for 67% of round participation.All available history.
Barer & Son Capital: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led133%
Participating267%
Barer & Son Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Barer & Son Capital: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Joshua Barer

Managing Partner